The New TSC Alert

  |  News

Welcome to the new TSC Alert, a monthly electronic newsletter for TSC researchers. It provides updates on TSC research resources, conferences and clinical studies, as well as news that may be relevant to investigators in the field. Read More

TSCRP funding opportunities available

The Tuberous Sclerosis Complex Research Program (TSCRP) is accepting applications for the fiscal year 2017 grant cycle. Letters of intent are due July 11, 2017. Three award mechanisms are available this year: Exploration – Hypothesis Development Award (up to $150,000 in direct costs over two years) Idea Development Award (up to $450,000 in direct costs over three years) Clinical Translational Research Award (up to $600,000 in direct costs over three years) Read More

Join Our Mendeley Groups

Do you use Mendeley to organize your citations? We have created a Mendeley group for all research articles on tuberous sclerosis complex and a smaller group for articles supported by TS Alliance funding. Please join our groups and contribute to the project by adding citations and documents. This will help us create a resource for researchers in the field and show our donors the impact of TS Alliance research funding. Read More

Early-Stage TSC Researchers Meeting – Deadline for Abstracts is May 8

Early-career researchers are invited to attend the Second Early-Stage Tuberous Sclerosis Complex Researcher Meeting on June 21, 2017. This meeting is organized by an international collective of early-career researchers and supported by the TS Alliance. If you are interested in giving a 10-minute platform presentation at this meeting, please submit your abstract to by Monday, May 8. Read More

2017 Research Grant Program Opens Monday

TS Alliance’s 2017 Research Grant Program will begin accepting letters of intent on Monday, April 10. Please see our Grants and Funding page for application instructions and a list of this year’s funding mechanisms. Read More

Call for Nominations: 2017 Manuel R. Gomez Award

  |  News

Nominations are being accepted until April 15, 2017, for the Manuel R. Gomez Award. This award is given in memory of Manuel R. Gomez, MD, the “Father of TSC” in the USA. Dr. Gomez provided care and compassion for hundreds of individuals with TSC during his career, and he sparked interest in the diagnosis and clinical care of individuals with TSC. A nominee should be someone who has made a significant impact on our understanding of TSC in research and/or impacted the delivery of clinical care for individuals with TSC. Read More

PREVeNT Trial Enrolling Participants

The Preventing Epilepsy Using Vigabatrin in Infants with Tuberous Sclerosis Complex (PREVeNT) trial, led by Martina Bebin at the University of Alabama Birmingham, is continuing to enroll participants at seven sites across the country. Read More

TSC Biosample Repository Update – March 2017

Our TSC Biosample Repository now has 203 blood samples from individuals with TSC (and some parents of children with TSC who do not have TSC themselves). These samples are linked to detailed clinical data in the TSC Natural History Database. High-quality biosamples and their associated clinical data will enable researchers to discover biomarkers, establish human cell lines or tissue arrays for drug testing, and search for clues to understand why TSC is so different from person to person. Read More